We are live on ! Find out more
FDMT icon

4D Molecular Therapeutics
FDMT

52 hedge funds and large institutions have $602M invested in 4D Molecular Therapeutics in 2020 Q4 according to their latest regulatory filings, with 52 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

55.09% more ownership

Funds ownership: 0% → 55.09% (+55%)

Holders
52
Holders Change
+52
Holders Change %
–
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
52
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
+$163M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$65.8M
3
BI
BVF Inc
California
+$45.7M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$43.9M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$42.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
EHI
26
Eagle Health Investments
Connecticut
$2.07M +$2.06M +50,000 New
JGC
27
J. Goldman & Co
New York
$2M +$1.99M +48,287 New
MWNA
28
Marshall Wace North America
New York
$1.49M +$1.48M +35,825 New
PPA
29
Parametric Portfolio Associates
Washington
$1.43M +$1.42M +34,444 New
SG Americas Securities
30
SG Americas Securities
New York
$1.4M +$1.39M +33,680 New
ECM
31
ExodusPoint Capital Management
New York
$1.37M +$1.37M +33,152 New
TD Asset Management
32
TD Asset Management
Ontario, Canada
$1.14M +$1.13M +27,448 New
ACP
33
Acuta Capital Partners
California
$829K +$826K +20,000 New
ACM
34
Aquilo Capital Management
California
$829K +$826K +20,000 New
PCM
35
Pinz Capital Management
New York
$825K +$821K +19,900 New
Qube Research & Technologies (QRT)
36
Qube Research & Technologies (QRT)
United Kingdom
$684K +$681K +16,496 New
Geode Capital Management
37
Geode Capital Management
Massachusetts
$529K +$528K +12,780 New
Mirae Asset Global Investments
38
Mirae Asset Global Investments
South Korea
$498K +$495K +12,000 New
M&T Bank
39
M&T Bank
New York
$435K +$433K +10,495 New
MIM
40
Monashee Investment Management
Massachusetts
$415K +$413K +10,000 New
Victory Capital Management
41
Victory Capital Management
Texas
$415K +$413K +10,000 New
Vanguard Group
42
Vanguard Group
Pennsylvania
$414K +$413K +10,000 New
MFS
43
Mirabella Financial Services
United Kingdom
$345K +$344K +8,330 New
EGM
44
Engineers Gate Manager
New York
$337K +$336K +8,139 New
Marshall Wace
45
Marshall Wace
United Kingdom
$308K +$307K +7,436 New
MS
46
Maven Securities
Jersey
$271K +$268K +6,500 New
BlackRock
47
BlackRock
New York
$246K +$245K +5,928 New
SAM
48
Sectoral Asset Management
Quebec, Canada
$217K +$216K +5,224 New
CCM
49
CAAS Capital Management
New York
$207K +$206K +5,000 New
Norges Bank
50
Norges Bank
Norway
$207K +$206K +5,000 New
1
2
3

FDMT Hedge Fund Activity: Q4 2020 in Review

52 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in 4D Molecular Therapeutics (FDMT) for Q4 2020, worth a combined $602M.

Buyers outnumbered sellers: 52 funds opened new FDMT positions and 0 closed out — a net gain of 52 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Viking Global Investors, opening a new position worth an estimated $163M.

  • 52 institutional investors held 4D Molecular Therapeutics (FDMT) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $602M of 4D Molecular Therapeutics stock for Q4 2020.
  • 52 funds opened new 4D Molecular Therapeutics positions in Q4 2020 and 0 closed out, a net change of +52 holders.
  • The largest 4D Molecular Therapeutics buyer in Q4 2020 was Viking Global Investors, an estimated $163M added.

Based on aggregated 13F filings for Q4 2020.